TUESDAY, Oct. 1, 2019 — Rituxan (rituximab) injection was granted the first approval for a drug to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in combination with glucocorticoids in children 2 years and older, the U.S. Food and Drug Administration announced Friday. The agency noted that pediatric patients with GPA, previously known as… Read More »
by Jessica Sieff A new report from the World Health Organization says initial results from a five-year study into the efficacy of spatial repellents encourage further research into their potential impact to reduce infection of vector-borne diseases including malaria, Zika and dengue fever. According to researchers at the University of Notre Dame, data from a clinical trial… Read More »
The immune system normally defends the body against everything from microscopic viruses to meters-long parasitic worms. But sometimes, it sets its sights on the wrong target: the body’s own cells. Autoimmunity problems cause many different diseases, depending on which cells are targeted. In Type 1 diabetes, it’s beta cells. Beta cells are located in the… Read More »
December 21st, 2018 Editors Diagnostics, Neurology, Rehab Grip strength, as well as walking speed and gait length, can be indicators of a person’s physical and mental health. A variety of conditions and treatments can be monitored from the grip strength, but such measurements are typically only performed infrequently at the doctor’s office. IBM Research has… Read More »